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Introduction
WHO report, approximately 150 million people have diabetes mellitus worldwide, and this number may well double by the year 2025. Statistical projection suggests that the number of diabetics will rise from 15 million in the year 1995 to 57 million in 2025, making India the country with the highest number of diabetics in the world. Although many drugs and interventions are available to manage diabetes, these are expensive for a developing country like India apart from their inherent adverse effects. Therefore, it is necessary to look for new avenues to manage this major health problem.
As part of the pathogenesis of noninsulin-dependent diabetes mellitus (NIDDM), the skeletal muscle, liver and adipose tissues become resistant to the hormonal effects of insulin, which in turn leads to decreased insulin-mediated glucose disposal, hepatic glucose overproduction and a marked increase in lipolysis. [1] In addition to the above, hyperatherosclerosis, which are responsible for substantial morbidity and premature mortality. Hence, in addition to glycemic control, management of hyperinsulinemia is also essential for limiting these after-effects of NIDDM.
[1]
Numerous herbal drugs like Momordica charantia, Tinospora cordifolia, Terminalia cattapa, Melia azadirachta and Syzygium cumini have been used by people of various cultures to treat diabetes. [2] Similarly, ayurveda, an ancient Indian system of medicine, mentions several plants that are useful in the correction of metabolic disorders such as diabetes mellitus. One herbomineral preparation that has been formulated with plants mentioned in ayurvedic texts and manufactured by Shrushti Herbal Pharma, Bangalore, India, is SH-01D.
Each tablet of SH-01D contains aqueous extracts equivalent to Guduchi (Tinospora cardifolia) 80 mg, Saptachakra (Salacia reticulata) 80 mg, Bilva (Aegle marmelos) 20 mg, Neem 
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Materials and Methods
(cholesterol oxidase method), triglyceride and insulin (radioimmunoassay method). Then the animals were sacrificed, a piece of liver and thigh muscle tissues were dissected out, Wistar albino rats of both sex (175-200 g) and female albino weighed and immediately digested with 2 ml of 30 % KOH mice (20-25 g) were procured from Drug Testing Laboratory, solution separately, for determination of glycogen as per the Bangalore and maintained at 25±1 0 C temperature and relative method described by Montgomery.
[9]
humidity of 45-55% under 12:12 h light:dark cycle. The animals Resistance Index (FIRI) was calculated using the formula, of the control and the dexamethasone groups had free access FIRI= (Fasting insulin X Fasting glucose)/25 to tap water while the other groups were fed with 10% fructose Chemicals and biochemical estimations in drinking water. All the groups were fed with rat-food pellet For estimation of glucose, triglyceride and cholesterol, kits ad libitum (Lipton, India). The experimental protocols were (Span diagnostics, India) were used. Serum insulin was approved by the Institutional Animal Ethics Committee of estimated by radioimmunoassay (RIA) using RIA kit , INSIK-5 Government College of Pharmacy, Bangalore, India, and were (Diasorin, Italy), with a gamma counter. All the estimations in accordance with the guidelines of the Committee for the were carried out as per the instructions provided by the kit Purpose of Control and Supervision on Experiments on manufacturers. Glycogen was determined as per the method Animals. Water was used as vehicle for preparing mentioned earlier.
Statistical analysis
The data were expressed as mean±SEM. The statistical Acute toxicity of SH-01D was determined using female significance between means was analyzed using one-way albino mice. The animals were fasted 3 h prior to the analysis of variance (ANOVA) followed by Tukey multiple experiment according to the procedure (OECD guideline no.
comparison test. A P<0.05 was considered as statistically 425) and were observed for 48 h following oral administration significant. of different doses of SH-01D, as per the guidelines.
[3]
Results
Experimental design
Acute toxicity of SH-01D in mice Dexamethasone induced insulin resistance model [4] [5] [6] The animals were observed for mortality for 48 h, and the Animals were divided into 4 groups, each consisting of preparation was found to be safe upto a dose of 5000 mg/kg, b.w. In groups 2-4, dexamethasone was administered to the overnight-fasted rats and continued till the end of the experiment along with SH-01D 30 or 60 mg/kg, b.w., p.o., in two divided doses in water. At the end of the experimental period, i.e. on day 11, the animals were anesthetized with ether; blood was collected by retroorbital puncture and serum separated for the estimation of glucose (glucose oxidase method) and triglyceride (GPO). The animals were weighed at the beginning and at the end of the experimental period.
Fructose-induced insulin resistance model [7, 8] The animals were divided into three groups of six rats each. Table 2 ] The SH-01D (60 mg/kg, p.o.) along with dexamethasone for 10 days had significantly reduced the serum biochemical parameters like glucose and triglycerides (P<0.001) as compared to dexamethasone alone treated group. There was a significant (P<0.001) reduction in body weight in dexamethasone-treated rats when compared to normal control. [ Table 2 ] Treatment with SH-01D at 60 mg/kg significantly prevented the loss in body weight. However SH-01D at 30 mg/kg did not produce any significant effect on the above parameters.
Effect of SH-01D in fructose-induced insulin resistance model in rats
Fructose feeding significantly increased serum glucose, insulin, FIRI index, cholesterol, triglyceride and LDL when compared to normal rats. [Table1, Figure 1 ] However, there Prevention of insulin resistance in rats by SH-01D was no significant effect on HDL levels. Giving SH-01D (60 mg/kg, p.o.) along with fructose feeding for 20 days significantly (P<0.001) reduced the said biochemical parameters like glucose, insulin and FIRI values when compared to fructose alone fed group. [ Table 1 ] Discussion
Insulin resistance in humans has been shown to be present in conditions like NIDDM, obesity and dyslipidemia. Thus interventions to decrease insulin resistance may postpone the development of NIDDM and its complications. Treatment with natural herbs is likely to be fraught with lesser side effects compared to the presently used synthetic oral antidiabetic was evident from the decreased glucose and insulin and increased liver and skeletal muscle glycogen stores. The drugs ameliorating hyperinsulinemia are likely to have greater therapeutic potential as they may also exert beneficial effects on the clinical course of NIDDM, hypertension and coronary artery disease conditions.
In conclusion, oral administration of SH-01D at a dose of 60 mg/kg lowers serum glucose, insulin, triglyceride and LDL concentrations in fructose-fed rats and similarly reduces serum triglyceride and glucose levels in dexamethasone-administered rats. If these results are extrapolated to humans then SH 01D might prove useful in the treatment and/or prevention of insulin resistance in nondiabetic states such as obesity and agents. Among the various constituents of SH-01D, the aqueous impaired glucose tolerance. However, detailed toxicity profile leaf extract of Melia azadirachta has been reported to possess is needed to determine the suitability of SH-01D for clinical significant antidiabetic effect in both type 1 and type 2 diabetes models as well as improved glucose tolerance. [10, 11] Vats usage.
have shown that the extract of Tinospora cardifolia Acknowledgments had significant antihyperglycemic effect. Das et al, [13] have found the aqueous extract of the leaves of Aegle marmelos to have
We are grateful to Dr Shubha Hegde, Managing Director, Shrushti Herbal Pharma significant hypoglycemic activity in both normal and Ltd, Bangalore, for providing the gift sample of the investigational drug and finan cial assistance. We also thank Prof. M. Lakshmana, ex-Principal, Government. Col streptozotocin-diabetic rats, through stimulation of the lege of Pharmacy, Bangalore, for providing the necessary facilities for the study.
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